Breakthrough for prostate cancer patients as NHS now offers life-extending drug - The new medication is suitable for patients ...

The research focused on the genetic faults that allow the disease to hijack a signalling system in the body.

Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its potential to improve treatment outcomes. The designation is based on phase 1 ...

Sofetabart mipitecan received FDA breakthrough therapy designation for platinum-resistant ovarian cancer after prior ...

Eli Lilly and Co. has received the U.S. Food and Drug Administration’s breakthrough therapy designation for a drug in ...

UF Health Cancer Institute scientists found a bacterial compound that may double lung cancer treatment effectiveness in mice.

Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough ...

Researchers have shared a groundbreaking development in cancer treatment research with new technology that can selectively target cancerous cells whilst sparing healthy tissue. A team at RMIT ...

HHMI Investigator Kevan Shokat and his lab are charting new therapies to outmaneuver drug resistance and better target common cancer cell mutations.

Fox News senior medical analyst Dr. Marc Siegel joins ‘Fox & Friends’ to discuss a new study on breast cancer treatment and ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...